Fiomi Diagnostics AB develops and manufacture:
Meritas® Troponin I, Meritas® BNP assays and Meritas® POC Analyzer
With its current and future menu of tests, sets a new standard for point-of-care testing, including the only guideline- compliant POC Troponin assay – the Meritas® Troponin I test. This allows fast, cost-effective and accurate triage, enabling rapid intervention for improved patient outcomes.
Fiomi Diagnostics AB is a wholly owned subsidiary of Trinity Biotech plc. Trinity Biotech plc is a public company, specializing in the development, manufacture and marketing of clinical diagnostic products